Pdt Partners, LLC Spectrum Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.9 - $4.09 $503,150 - $709,615	-173,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $80,085 - $121,787	23,694 Added 15.82%	173,500 $592,000
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $335,495 - $549,809	112,206 Added 298.42%	149,806 $611,000
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $187,368 - $300,144	-88,800 Reduced 70.25%	37,600 $127,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $28,365 - $53,475	-15,500 Reduced 10.92%	126,400 $295,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $96,393 - $285,049	27,541 Added 24.08%	141,900 $517,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $803,943 - $1.11 Million	114,359 New	114,359 $949,000
Q4 2017 Feb 14, 2018	SELL	$13.36 - $20.73 $1.9 Million - $2.94 Million	-142,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $1.24 Million - $2 Million	142,000	142,000 $2 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.